Interviews

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient's renal function affects appropriate dosing of new oral anticoagulants.

James Hoffman, PharmD, MS, FASHP, explains how pharmacy practice settings may change going forward.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses developing trends in specialty drug cost management.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.

Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses the role of the pharmacist in optimizing care for heart failure with reduced ejection fracture patients.

James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, outlines how pharmacists can use their knowledge of key trends to patient care improvement efforts.

Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses how the approval of Entresto changed the heart failure care landscape.

David Lassen, chief clinical officer at Prime Therapeutics, discusses implications for specialty pharmacy from health care reform.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about some ways a pharmacy can differentiate itself from its competition.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about what happens to a pharmacy if it is found to be out of compliance with DEA regulations or federal statutes.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses why specialty pharmacies should seek accreditation.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about some safeguards pharmacists can implement.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses developments affecting the specialty landscape.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.

Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses techniques specialty pharmacies can use to improve workflow and clinical activities in therapy management.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, discusses why she thinks her pharmacy was named best Retail Advantage by Cardinal Health.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about how telling your pharmacy story can improve your pharmacy's brand and nurture patient loyalty.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can maintain business continuity during a natural disaster or other emergencies.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some ways independent pharmacists could encourage local prescribers to adopt e-prescribing of controlled substances.

Liz Tiefenthaler, president of Pharm Fresh Media, provides some examples of how marketing techniques or outreach efforts differ based on patient demographics.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, gives some examples of sustainable business models that can expand the role of the pharmacist.

Carlos Aquino, founder and president of PharmaDiversion LLC, reviews some of the DEA's requirements for handling controlled substances.